Pittman, P. R., Norris, S. L., Brown, E. S., Ranadive, M. V., Schibly, B. A., Bettinger, G. E., . . . Peters, C. J. (2015). Rift Valley Fever MP-12 Vaccine Phase 2 Clinical Trial: Safety, Immunogenicity, and Genetic Characterization of Virus Isolates. Vaccine.
Styl cytowania ChicagoPittman, Phillip R., et al. "Rift Valley Fever MP-12 Vaccine Phase 2 Clinical Trial: Safety, Immunogenicity, and Genetic Characterization of Virus Isolates." Vaccine 2015.
Styl cytowania MLAPittman, Phillip R., et al. "Rift Valley Fever MP-12 Vaccine Phase 2 Clinical Trial: Safety, Immunogenicity, and Genetic Characterization of Virus Isolates." Vaccine 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..